DCGI asked to stop over-the-counter sale of nicotine gums by the Delhi government

  • News
  • December 24, 2017

The Delhi government’s health department sent written request to the Drug Controller General of India (DGCI) to stop the over-the-counter sale of nicotine gums and lozenges without an authorized prescription. Dr. SK Arora in a letter addressing Dr. GN Singh, additional director (Health) said nicotine have potential addiction property and people can use like a drug in the form of gums and lozenges which were being sold at medical shops over the counter without any prescription.

During counseling, motivation and behavioral therapy, People addicted to a small percentage of moderate tobacco users may require these drugs as nicotine replacement therapy (NRT) under the supervision of qualified counsellors. But the selling of these drugs over the counter without any prescription promotes malpractices and self-therapy, it may lead to merely shifting the person from one addiction to another, the letter read.

Dr. Arora said the youngsters who can’t use tobacco products directly due to social or family fear may easily use them, s they should stop selling over counters.

  • Related Posts

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Rajasthan Drops 1,114 Hospitals From RGHS in Fraud Drive

    Jaipur, August 18, 2025 — Rajasthan has removed 1,114 private hospitals from the Rajasthan Government Health Scheme (RGHS) after a statewide fraud sweep. The Health Department also suspended 1,901 healthcare…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid